Epigenetic Deregulation of MicroRNAs: New Opportunities to Target Oncogenic Signaling Pathways in Hepatocellular Carcinoma

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|7|1192-1200

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.7, 2013-02, pp. : 1192-1200

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MicroRNAs Contribute to Hepatocellular Carcinoma

By  

Mini Reviews in Medicinal Chemistry, Vol. 15, Iss. 6, 2015-05 ,pp. : 459-466

Bentham Science Publishers

Access to resources Recommend Favorite

Circulating microRNAs in Hepatocellular Carcinoma: Potential Diagnostic and Prognostic Biomarkers

By  

Current Pharmaceutical Design, Vol. 22, Iss. 34, 2016-11 ,pp. : 5257-5269

Bentham Science Publishers

Access to resources Recommend Favorite

The Expression Patterns and Clinical Significance of microRNAs in Liver Diseases and Hepatocellular Carcinoma

By  

Current Pharmaceutical Design, Vol. 19, Iss. 7, 2013-02 ,pp. : 1262-1272

Bentham Science Publishers

Access to resources Recommend Favorite

MicroRNAs: A Novel Therapeutic Target for Schizophrenia

By  

Current Pharmaceutical Design, Vol. 17, Iss. 2, 2011-01 ,pp. : 176-188

Bentham Science Publishers

Access to resources Recommend Favorite

An Updated Portrait of Pathogenesis, Molecular Markers and Signaling Pathways of Hepatocellular Carcinoma

By  

Current Pharmaceutical Design, Vol. 23, Iss. 16, 2017-06 ,pp. : 2356-2365

Bentham Science Publishers

Access to resources Recommend Favorite